Difference between revisions of "Part:BBa K4414026"
Line 3: | Line 3: | ||
<partinfo>BBa_K4414026 short</partinfo> | <partinfo>BBa_K4414026 short</partinfo> | ||
− | This composite part consists of an N-terminal | + | This composite part consists of an N-terminal GR<sub>LBD</sub>([[Part:BBa_K4414000]]) domain and a C-terminal tetR([[Part:BBa_K4414009]]) domain fused with a GGGGGSG linker. It is designed to sense glucocorticoids and activates the transcription of the reporter gene. |
Line 63: | Line 63: | ||
==Reference== | ==Reference== | ||
− | 1.Weikum | + | 1. Weikum, E. R., Knuesel, M. T., Ortlund, E. A., & Yamamoto, K. R. (2017). Glucocorticoid receptor control of transcription: precision and plasticity via allostery. Nat Rev Mol Cell Biol, 18(3), 159-174. doi:10.1038/nrm.2016.152 |
− | 2.Shao J, Qiu X, Xie M. Engineering Mammalian Cells to Control Glucose Homeostasis. Methods Mol Biol | + | 2. Shao, J., Qiu, X., & Xie, M. (2021). Engineering Mammalian Cells to Control Glucose Homeostasis. Methods Mol Biol, 2312, 35-57. doi:10.1007/978-1-0716-1441-9_3 |
Revision as of 14:05, 11 October 2022
LBD-GGGGGSG-tetR
This composite part consists of an N-terminal GRLBD(Part:BBa_K4414000) domain and a C-terminal tetR(Part:BBa_K4414009) domain fused with a GGGGGSG linker. It is designed to sense glucocorticoids and activates the transcription of the reporter gene.
Usage and Biology
As a glucocorticoid sensor, this part is designed to enter the nucleus upon glucocorticoid stimulation and bind to the TCE promoter to activate downstream transcription. This part consists of a tetR DNA binding domain, which binds to the TCE promoter (Part:BBa_K4016011) consisting of seven direct 19-bp tet operator sequence (tetO) repeats. The NR3C1 LBD domain on the N terminal is the ligand binding domain of the glucocorticoid receptor(GR). This LBD domain can translocate the fusion protein into the nucleus upon glucocorticoid stimulation. It also has a transactivating domain 2 (τ2) and an activation function domain 2 (AF2) which activates downstream gene expression.(Weikum et al., 2017)
Figure1. Schematic figure of BBa_K4414026 and (Part:BBa_K4414041)
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
Functional Test
To test the ability of this part to respond to glucocorticoids, HEK-293T cells were co-transfected with plasmids encoding both (BBa_K4414026) and TCE-SEAP(Part:BBa_K4414041).
Method
Cells were treated with 10, 50, or 100 nM Glucocorticoids 6 h post-transfection. Cells without glucocorticoid treatment were used as control. Culture medium was collected at 24 h or 48 h post glucocorticoids treatment. SEAP activity was measured according to a published protocol. (Shao et al., 2021) Figure2.Schematic representation of the experimental process of validation for BBa_K4414026 and (Part:BBa_K4414041).
Result
Results showed significantly increased SEAP expression in glucocorticoid-treated cells compared to the non-treated control (2-20 folds). A dose dependence was observed within 0-100 nM of glucocorticoid (Figure 3). Figure3. Glucocorticoid-stimulated transcriptional activation of SEAP mediated by BBa_K4414026.
Reference
1. Weikum, E. R., Knuesel, M. T., Ortlund, E. A., & Yamamoto, K. R. (2017). Glucocorticoid receptor control of transcription: precision and plasticity via allostery. Nat Rev Mol Cell Biol, 18(3), 159-174. doi:10.1038/nrm.2016.152
2. Shao, J., Qiu, X., & Xie, M. (2021). Engineering Mammalian Cells to Control Glucose Homeostasis. Methods Mol Biol, 2312, 35-57. doi:10.1007/978-1-0716-1441-9_3